Fagron N.V.
A global pharmaceutical compounding company focused on personalized medicine.
FAGR | BR
Overview
Corporate Details
- ISIN(s):
- BE0003874915
- LEI:
- 549300TRKRUFK2RRG779
- Country:
- Belgium
- Address:
- Venecoweg 20A, 9810 Nazareth
- Website:
- https://fagron.com/
- Sector:
- Manufacturing
Description
Fagron N.V. is a global company active in pharmaceutical compounding, focusing on the delivery of personalized medicine. The company optimizes and innovates compounding to widen the therapeutic options for prescribers worldwide. Fagron develops, markets, and distributes pharmaceutical raw materials, equipment, and specially formulated vehicles and bases, such as the Pentravan® transdermal base and the SyrSpend® range of oral suspending vehicles. Its primary customers are hospitals, pharmacies, and clinics. The company also operates in the field of genomics to further support personalized healthcare solutions.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2017-04-30 18:00 |
Compliance certficate 300417 DEF.pdf
|
English | 58.5 KB | ||
| 2017-04-30 18:00 |
Verklaring van nakoming 300417 DEF.pdf
|
Dutch | 58.0 KB | ||
| 2017-04-30 18:00 |
Guarantor list 300417 DEF.pdf
|
English | 148.1 KB | ||
| 2017-04-30 18:00 |
Garantenlijst 300417 DEF.pdf
|
Dutch | 136.4 KB | ||
| 2017-04-30 18:00 |
Publication of Guarantor List and Compliance Certificate
|
English | 68.8 KB | ||
| 2017-04-30 18:00 |
Publicatie van Garantenlijst en Verklaring van Nakoming
|
Dutch | 60.0 KB | ||
| 2017-04-13 07:14 |
Fagron: Turnover increases by 7.1% to € 109.9 million
|
English | 259.7 KB | ||
| 2017-04-13 07:14 |
Fagron: Turnover increases by 7.1% to € 109.9 million
|
English | 263.9 KB | ||
| 2017-04-13 07:00 |
ENG DEF Trading Update Q1-17.pdf
|
English | 259.7 KB | ||
| 2017-04-13 07:00 |
NED DEF Trading Update Q1-17.pdf
|
Dutch | 263.9 KB | ||
| 2017-04-07 07:25 |
Fagron NV: Convocation annual meeting and extraordinary general meeting
|
English | 140.5 KB | ||
| 2017-04-07 07:25 |
Fagron NV: Convocation annual meeting and extraordinary general meeting
|
English | 142.1 KB | ||
| 2017-04-07 07:00 |
Verslag 604 RvB toegestaan kapitaal.pdf
|
Dutch | 687.7 KB | ||
| 2017-04-07 07:00 |
ENG Proxy AGM 8 May 2017.pdf
|
English | 1.2 MB | ||
| 2017-04-07 07:00 |
NE Achtergrondinformatie AVA 8 mei 2017.pdf
|
Dutch | 513.9 KB |
Automate Your Workflow. Get a real-time feed of all Fagron N.V. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Fagron N.V.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Fagron N.V. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-05-23 | Pulido Andrew | Executive member | Sell | 85,000 | 1,803,351.50 EUR |
| 2025-05-22 | Pulido Andrew | Executive member | Buy | 85,000 | 1,617,550.00 EUR |
| 2025-05-02 | De Jong Cornelia Neeltje | Board | Sell | 12,689 | 263,834.55 EUR |
| 2025-04-30 | De Jong Cornelia Neeltje | Board | Sell | 229 | 4,660.15 EUR |
| 2025-04-29 | De Jong Cornelia Neeltje | Board | Sell | 10,000 | 201,500.00 EUR |
| 2025-03-28 | J. Verlinden | Other | Buy | 24,551 | 453,702.48 EUR |
| 2025-03-28 | J. Verlinden | Other | Sell | 17,930 | 344,047.56 EUR |
| 2025-03-27 | Padilla Rafael | Board | Buy | 78,469 | 1,450,107.12 EUR |
| 2025-03-27 | De Jong Cornelia Neeltje | Board | Buy | 45,418 | 839,324.64 EUR |
| 2025-02-21 | Bakker Vera | Executive member | Buy | 773 | 15,000.00 EUR |
Peer Companies
